RAS from Discovery to Therapy and Beyond: Molecular Oncology Program "Bridging the Gap" Retreat
Thursday, March 26 at 11:30 am
-
5:00 pm
Add to Calendar
2026-03-26 11:30:00
2026-03-26 17:00:00
RAS from Discovery to Therapy and Beyond: Molecular Oncology Program "Bridging the Gap" Retreat
Molecular Oncology Program "Bridging the Gap" Retreat:
RAS from Discovery to Therapy and Beyond
Please join us for a multidisciplinary “Bridging the Gap” retreat focused on the development of RAS inhibitors in cancer therapy. We will bring together pre-clinical discovery scientists, clinicians and stakeholders to encourage collaboration and strategic planning for future discovery/development efforts. Keynote speakers include Frank McCormick (UCSF), Kevan Shokat (UCSF) and Mallika Singh (Revolution Medicines).
AGENDA
11:30 am - 12 pm | Lunch and Introduction
Introduction by Charly Craik, PhD
12 - 12:30 pm | A Brief History of RAS in Cancer
Frank McCormick, PhD, FRS
12:30 - 2 pm | Current Clinical Use of RAS Inhibitors
Lung Cancer
Matt Gubens, MD
Pancreas Cancer
John Gordan, MD, PhD
Panel Discussion with Q and A
Pamela Munster, MD (Moderator)
2:15 - 3:45 pm | Emerging Frontiers
Resistance to Ras Inhibitors in the Clinic
Trever Bivona, MD, PhD
New Compounds in Development
Pamela Munster, MD
What’s next in drugging RAS: Emerging Targets and New Technologies
Mallika Singh, PhD
Panel Discussion with Q and A
Cathy Smith, MD (Moderator)
3:45 - 4:15 pm | Exciting Things to Come in RAS
Kevan Shokat, PhD
4:15 - 5 pm | Reception and networking
>> REGISTER TO ATTEND
-----
This event is open to all interested researchers at UCSF.
Presented by the Molecular Oncology Program of the Helen Diller Family Comprehensive Cancer Center. For questions, please contact Meredith Donnelly ([email protected]).
1450 3rd Street
HD-160
San Francisco, CA 94158
United States
View on Map
Helen Diller Family Comprehensive Cancer Center
[email protected]
America/Los_Angeles
public
1450 3rd Street
HD-160
San Francisco, CA 94158
United States
View on Map
Molecular Oncology Program "Bridging the Gap" Retreat:
RAS from Discovery to Therapy and Beyond
Please join us for a multidisciplinary “Bridging the Gap” retreat focused on the development of RAS inhibitors in cancer therapy. We will bring together pre-clinical discovery scientists, clinicians and stakeholders to encourage collaboration and strategic planning for future discovery/development efforts. Keynote speakers include Frank McCormick (UCSF), Kevan Shokat (UCSF) and Mallika Singh (Revolution Medicines).
AGENDA
11:30 am - 12 pm | Lunch and Introduction
Introduction by Charly Craik, PhD
12 - 12:30 pm | A Brief History of RAS in Cancer
Frank McCormick, PhD, FRS
12:30 - 2 pm | Current Clinical Use of RAS Inhibitors
- Lung Cancer
Matt Gubens, MD
- Pancreas Cancer
John Gordan, MD, PhD
- Panel Discussion with Q and A
Pamela Munster, MD (Moderator)
2:15 - 3:45 pm | Emerging Frontiers
- Resistance to Ras Inhibitors in the Clinic
Trever Bivona, MD, PhD
- New Compounds in Development
Pamela Munster, MD
- What’s next in drugging RAS: Emerging Targets and New Technologies
Mallika Singh, PhD
- Panel Discussion with Q and A
Cathy Smith, MD (Moderator)
3:45 - 4:15 pm | Exciting Things to Come in RAS
Kevan Shokat, PhD
4:15 - 5 pm | Reception and networking
>> REGISTER TO ATTEND
-----
This event is open to all interested researchers at UCSF.
Presented by the Molecular Oncology Program of the Helen Diller Family Comprehensive Cancer Center. For questions, please contact Meredith Donnelly ([email protected]).